IN2014CN03368A - - Google Patents

Download PDF

Info

Publication number
IN2014CN03368A
IN2014CN03368A IN3368CHN2014A IN2014CN03368A IN 2014CN03368 A IN2014CN03368 A IN 2014CN03368A IN 3368CHN2014 A IN3368CHN2014 A IN 3368CHN2014A IN 2014CN03368 A IN2014CN03368 A IN 2014CN03368A
Authority
IN
India
Prior art keywords
surface marker
cell surface
purification
vectors
viral
Prior art date
Application number
Other languages
English (en)
Inventor
Chiara Bovolenta
Anna Stornaiuolo
Original Assignee
Molmed Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molmed Spa filed Critical Molmed Spa
Publication of IN2014CN03368A publication Critical patent/IN2014CN03368A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN3368CHN2014 2011-10-05 2012-10-05 IN2014CN03368A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11183937 2011-10-05
PCT/EP2012/069713 WO2013050523A1 (fr) 2011-10-05 2012-10-05 Système de purification de vecteurs viraux

Publications (1)

Publication Number Publication Date
IN2014CN03368A true IN2014CN03368A (fr) 2015-07-03

Family

ID=47071247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3368CHN2014 IN2014CN03368A (fr) 2011-10-05 2012-10-05

Country Status (13)

Country Link
US (1) US20140248695A1 (fr)
EP (1) EP2764094A1 (fr)
JP (1) JP2014528729A (fr)
KR (1) KR20140068259A (fr)
CN (1) CN103842501B (fr)
AU (1) AU2012320480A1 (fr)
BR (1) BR112014008225A2 (fr)
CA (1) CA2848939A1 (fr)
IL (1) IL231876A0 (fr)
IN (1) IN2014CN03368A (fr)
RU (1) RU2607044C2 (fr)
WO (1) WO2013050523A1 (fr)
ZA (1) ZA201401481B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2480678B1 (fr) 2010-09-02 2014-02-12 Molmed SpA Production stable de vecteurs lentiviraux
GB201310664D0 (en) 2013-06-14 2013-07-31 Mars Inc Feline taste receptors
CA3019133A1 (fr) * 2016-03-31 2017-10-05 Spark Therapeutics, Inc. Procede de fabrication de raav entierement extensible base sur une colonne

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654183A (en) * 1992-07-27 1997-08-05 California Institute Of Technology Genetically engineered mammalian neural crest stem cells
IT1261847B (it) 1993-09-01 1996-06-03 San Romanello Centro Fond Metodo per marcare cellule eucariote.
WO1996007747A1 (fr) * 1994-09-08 1996-03-14 Boehringer Mannheim Gmbh Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
EP1284287A4 (fr) * 2000-05-10 2004-10-13 Mitsubishi Pharma Corp Procede de preparation de vecteur de virus
AU9307501A (en) * 2000-09-22 2002-04-02 Virxsys Improved conditionally replicating vectors, methods for their production and use
GB0224442D0 (en) * 2002-10-21 2002-11-27 Molmed Spa A delivery system
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase
JP3968383B2 (ja) * 2004-09-01 2007-08-29 株式会社日本メディカル総研 血液細胞の新規分類法ならびにそれを利用したテイラーメード治療および予防
EP1739180A1 (fr) * 2005-06-27 2007-01-03 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Lignée cellulaire d'enrobage à base de lymphocytes T, pour la production des rétrovirus en enrichant des cellules exprimant CD3
JP4921083B2 (ja) * 2005-09-13 2012-04-18 タカラバイオ株式会社 レトロウィルス産生用無血清培地
WO2011060218A1 (fr) * 2009-11-13 2011-05-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ligand de mort programmée 1 modulé
GB0920775D0 (en) * 2009-11-26 2010-01-13 King S College Cells
KR101891626B1 (ko) 2010-09-02 2018-09-28 몰메드 에스피에이 렌티바이러스 벡터의 반-안정성 산물
EP2480678B1 (fr) 2010-09-02 2014-02-12 Molmed SpA Production stable de vecteurs lentiviraux

Also Published As

Publication number Publication date
RU2014117466A (ru) 2015-11-10
BR112014008225A2 (pt) 2017-04-11
AU2012320480A1 (en) 2014-04-24
WO2013050523A1 (fr) 2013-04-11
RU2607044C2 (ru) 2017-01-10
CA2848939A1 (fr) 2013-04-11
ZA201401481B (en) 2015-04-29
JP2014528729A (ja) 2014-10-30
IL231876A0 (en) 2014-05-28
NZ623092A (en) 2016-07-29
US20140248695A1 (en) 2014-09-04
EP2764094A1 (fr) 2014-08-13
CN103842501B (zh) 2017-12-08
CN103842501A (zh) 2014-06-04
KR20140068259A (ko) 2014-06-05

Similar Documents

Publication Publication Date Title
MX2015014720A (es) Mutante de epimerasa psicosa y metodo para preparar psicosa mediante el uso del mismo.
SG10201806498RA (en) Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
IN2015DN02771A (fr)
JO3306B1 (ar) تراكيب وطرق لطلاء الأظافر قابل للمعالجة بالأشعة فوق البنفسجية
UA114796C2 (uk) Спосіб підвищення ефективності трансдукції
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
AU2011356210A8 (en) Novel fucosyltransferases and their applications
PT3008172T (pt) Composições de meio de cultura para maturar cardiomicóticos derivados de células estaminais pluripotentes de mamíferos
ZA201302939B (en) Expression vector for high level expression of recombinant proteins
MX354516B (es) Vectores que codifican el factor de viabilidad de conos derivado de bastones.
IN2014CN01706A (fr)
MX2020003508A (es) Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.
WO2012102527A3 (fr) Nouvelle utilisation de la protéine de surface lrig-1 régulatrice spécifique des cellules t
PH12018500155A1 (en) Recombinant orf virus vector
MX2016011465A (es) Drimenol-sintasas y metodos para producir drimenol.
IL230519A0 (en) Virus-based vector constructs used to transform eukaryotic cells
IN2014CN02963A (fr)
IN2014DN10111A (fr)
IN2014DN09367A (fr)
WO2013096683A3 (fr) Augmentation de la production d'isoprène avec des cellules bactériennes marines
IN2014CN03368A (fr)
EP2539440A4 (fr) Dérivation de cellules hématopoïétiques à partir de cellules souches mesenchymateuses adultes
MX2014006869A (es) Cassette de expresion.
IN2014DN09097A (fr)
WO2012054935A3 (fr) Formation de cellules progénitrices hématopoïétiques provenant de cellules souches mésenchymateuses